ArticleMolecular cancer2013

Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines.

Hanneke Stegeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.